Home > Boards > Free Zone > Health and Sciences > Biotech Values

ABBV-AGN PR on $63B buyout:

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (7) | Next 10 | Previous | Next
DewDiligence Member Profile
Member Level 
Followed By 739
Posts 113,356
Boards Moderated 15
Alias Born 09/05/02
160x600 placeholder
DewDiligence Member Level  Tuesday, 06/25/19 09:58:30 AM
Re: biocqr post# 225375
Post # of 234228 
ABBV-AGN PR on $63B buyout:

https://finance.yahoo.com/news/abbvie-acquire-allergan-transformative-move-104200213.html
Quote:
Under the terms of the Transaction Agreement, Allergan Shareholders will receive 0.8660 AbbVie Shares and $120.30 in cash for each Allergan…for a total consideration of $188.24 per Allergan Share [based on ABBV’s 6/24/19 closing price]. The transaction represents a 45% premium to the closing price of Allergan's Shares on June 24, 2019.



“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (7) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist